Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
22.04. | Roche to Invest $50B in the U.S. | ||
22.04. | Carbogen Amcis Obtains Drug Manufacturing License from Chinese NMPA | ||
22.04. | Phlow Corp. Expands Analytical Capabilities & Invests in AI | ||
22.04. | Fujifilm Diosynth Biotechnologies & Regeneron Sign 10-Year U.S. Manufacturing Agreement | ||
22.04. | Jazz Pharmaceuticals Acquires Chimerix for $935M | ||
21.04. | BigHat & Lilly Partner on AI Antibody Discovery | ||
21.04. | FDA Approves Dupixent in the U.S. for Chronic Spontaneous Urticaria | ||
21.04. | Thermo Fisher Scientific Opens Advanced Therapies Collaboration Center | ||
21.04. | Rigaku and Spera Pharma Partner to Accelerate Pharmaceutical Development | ||
21.04. | Dipharma Earns Bronze EcoVadis Sustainability Rating | ||
17.04. | Neurizon Adds Strategic Regulatory and Scientific Leadership | ||
17.04. | Ziihera Now Available for HER2+ Biliary Cancer | ||
17.04. | Sanofi Licenses AI-Discovered Biologics from Earendil Labs | ||
16.04. | Capricorn Scientific Partners with florabio | ||
16.04. | Precision Medicine Group Appoints Chief Information and Technology Officer | ||
15.04. | BMS Heart Drug Camzyos Disappoints in Phase 3 Study | ||
15.04. | Parexel Names Chief Medical Officer | ||
15.04. | Cold Chain Technologies Launches CCT Tower Elite | ||
15.04. | Cyprumed Enters License and Option Agreement with MSD | ||
15.04. | Introducing Meribel Pharma Solutions | ||
15.04. | Celltrion's YUFLYMA Approved as Interchangeable Biosimilar to Humira | ||
15.04. | Boehringer Ingelheim, Cue Biopharma Partner to Commercialize Therapy for Immune Diseases | ||
15.04. | Galapagos CFO and COO Thad Huston Departs August 1 | ||
14.04. | Thermo Fisher Scientific Introduces 5L DynaDrive Single-Use Bioreactor | ||
14.04. | Lifecore Biomedical Taps Thomas Salus as Chief Legal & Administration Officer |